Collaborating on a large, international scale is the only effective way to find a cure for ALS. Therefore, the very best experts from top research centres across Europe have teamed up with patients’ organisations, fundraisers and pharma companies. By uniting our efforts, resources and talents, we will be quicker in realising our shared ambition: to find effective treatments for ALS.Read about our unique approach
Key to finding effective treatments is close collaborations with patients living with ALS. People affected by ALS lead the way, by participating in finding solutions to accelerate the development of novel effective treatments. Their voice is integrated in our organisation through the European patient association EUpALS, as well as through close collaboration with national patient organisations.
The TRICALS consortium is led by the Executive Board consisting of recognised global leaders in ALS clinical trial research as well as a patient public involvement representative affiliated to the European patient association EUPALS.
TRICALS is the world’s largest network of specialist ALS centers. Our unique network connects 44 of the very best ALS centres in 15 countries. All TRICALS centres are led by leading ALS experts and have an excellent track record in industry and investigator-initiated trial research. By uniting our efforts, resources and talents, we will be quicker in realising our shared ambition: to find effective treatments for ALS